HRP20100340T1 - Polipeptidi koji imaju antimikrobno djelovanje i polinukleotidi koji ih kodiraju - Google Patents

Polipeptidi koji imaju antimikrobno djelovanje i polinukleotidi koji ih kodiraju Download PDF

Info

Publication number
HRP20100340T1
HRP20100340T1 HR20100340T HRP20100340T HRP20100340T1 HR P20100340 T1 HRP20100340 T1 HR P20100340T1 HR 20100340 T HR20100340 T HR 20100340T HR P20100340 T HRP20100340 T HR P20100340T HR P20100340 T1 HRP20100340 T1 HR P20100340T1
Authority
HR
Croatia
Prior art keywords
polypeptide according
seq
polypeptide
acid sequence
amino acids
Prior art date
Application number
HR20100340T
Other languages
English (en)
Croatian (hr)
Inventor
Spodsberg Nikolaj
Original Assignee
Novozymes Adenium Biotech A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37056517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100340(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novozymes Adenium Biotech A/S filed Critical Novozymes Adenium Biotech A/S
Publication of HRP20100340T1 publication Critical patent/HRP20100340T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HR20100340T 2005-08-26 2006-08-22 Polipeptidi koji imaju antimikrobno djelovanje i polinukleotidi koji ih kodiraju HRP20100340T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200501190 2005-08-26
PCT/EP2006/065561 WO2007023163A1 (en) 2005-08-26 2006-08-22 Polypeptides having antimicrobial activity and polynucleotides encoding same

Publications (1)

Publication Number Publication Date
HRP20100340T1 true HRP20100340T1 (hr) 2010-07-31

Family

ID=37056517

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100340T HRP20100340T1 (hr) 2005-08-26 2006-08-22 Polipeptidi koji imaju antimikrobno djelovanje i polinukleotidi koji ih kodiraju

Country Status (28)

Country Link
US (1) US7745576B2 (enExample)
EP (1) EP1922333B1 (enExample)
JP (2) JP2009507474A (enExample)
KR (1) KR101362710B1 (enExample)
CN (2) CN101248085B (enExample)
AP (1) AP2008004415A0 (enExample)
AR (1) AR055394A1 (enExample)
AT (1) ATE462720T1 (enExample)
AU (1) AU2006283904B2 (enExample)
BR (1) BRPI0614968A2 (enExample)
CA (1) CA2620125C (enExample)
CY (1) CY1110024T1 (enExample)
DE (1) DE602006013330D1 (enExample)
DK (1) DK1922333T3 (enExample)
ES (1) ES2343586T3 (enExample)
HR (1) HRP20100340T1 (enExample)
IL (1) IL189135A0 (enExample)
MX (1) MX2008002485A (enExample)
NO (1) NO20081470L (enExample)
NZ (1) NZ565926A (enExample)
PL (1) PL1922333T3 (enExample)
PT (1) PT1922333E (enExample)
RS (1) RS51325B (enExample)
RU (1) RU2512525C2 (enExample)
SI (1) SI1922333T1 (enExample)
TW (1) TWI386416B (enExample)
WO (1) WO2007023163A1 (enExample)
ZA (1) ZA200801426B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2343586T3 (es) * 2005-08-26 2010-08-04 Novozymes Adenium Biotech A/S Polipeptidos con actividad antimicrobiana y polinucleotidos que codifican los mismos.
WO2007068735A1 (en) * 2005-12-14 2007-06-21 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
EP2248893A1 (en) 2009-05-06 2010-11-10 Novozymes A/S DFPase Enzymes from Octopus Vulgaris
US8653024B2 (en) 2009-12-11 2014-02-18 Adenium Biotech Aps Use of AMPs for treatment of UTI/cystitis
EP2336155A1 (en) * 2009-12-21 2011-06-22 Centre National de la Recherche Scientifique (CNRS) Antimicrobial peptides
US8835604B2 (en) * 2010-06-12 2014-09-16 Adenium Biotech Aos Antimicrobial peptide variants and polynucleotides encoding same
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
US8670119B1 (en) 2013-01-30 2014-03-11 Hewlett-Packard Development Company, L.P. Apparatus having surface-enhanced spectroscopy modules
CN106146629B (zh) * 2015-04-21 2020-03-31 中国农业科学院饲料研究所 一组胰蛋白酶抗性抗菌肽及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE4343591A1 (de) 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
JP3649338B2 (ja) 1994-06-03 2005-05-18 ノボザイムス バイオテック，インコーポレイティド 精製されたマイセリオフトラ・ラッカーゼ及びそれをコードする核酸
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
AU6188599A (en) 1998-10-26 2000-05-15 Novozymes A/S Constructing and screening a dna library of interest in filamentous fungal cells
CN1940067A (zh) 1999-03-22 2007-04-04 诺沃奇梅兹有限公司 用于在真菌细胞中表达基因的启动子
US6337317B1 (en) * 2000-06-27 2002-01-08 The University Of British Columbia Antimicrobial peptides and methods of use thereof
RU2261866C1 (ru) * 2004-02-10 2005-10-10 Институт Биоорганической химии им. акад. М.М. Шемякина и Ю.А. Овчинникова Российской Академии Наук ПЕПТИДЫ АРЕНИЦИНЫ, ВЫДЕЛЕННЫЕ ИЗ МОРСКОГО КОЛЬЧАТОГО ЧЕРВЯ ArenicolA marina, ОБЛАДАЮЩИЕ АНТИМИКРОБНЫМ ДЕЙСТВИЕМ
AR052947A1 (es) * 2005-03-18 2007-04-11 Novozymes As Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican para los mismos
US7534762B2 (en) * 2005-03-18 2009-05-19 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
WO2007009978A1 (en) * 2005-07-15 2007-01-25 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
ES2343586T3 (es) * 2005-08-26 2010-08-04 Novozymes Adenium Biotech A/S Polipeptidos con actividad antimicrobiana y polinucleotidos que codifican los mismos.
WO2007068735A1 (en) * 2005-12-14 2007-06-21 Novozymes A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
RU2316590C1 (ru) * 2006-06-16 2008-02-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pE-His8-TrxL-Ar2, КОДИРУЮЩАЯ ГИБРИДНЫЙ БЕЛОК, СОДЕРЖАЩИЙ АНТИМИКРОБНЫЙ ПЕПТИД АРЕНИЦИН МОРСКОГО КОЛЬЧАТОГО ЧЕРВЯ Arenicola marina, И ШТАММ Escherichia coli BL21(DE3)/pE-His8-TrxL-Ar2 - ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА, СОДЕРЖАЩЕГО АРЕНИЦИН
RU2316595C1 (ru) * 2006-06-16 2008-02-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Способ получения антимикробного пептида ареницина

Also Published As

Publication number Publication date
NO20081470L (no) 2008-05-26
PL1922333T3 (pl) 2010-09-30
RU2008111504A (ru) 2009-10-10
PT1922333E (pt) 2010-07-08
CA2620125A1 (en) 2007-03-01
CN101248085A (zh) 2008-08-20
SI1922333T1 (sl) 2010-06-30
CY1110024T1 (el) 2015-01-14
AU2006283904A1 (en) 2007-03-01
JP2009507474A (ja) 2009-02-26
ES2343586T3 (es) 2010-08-04
RU2512525C2 (ru) 2014-04-10
JP2013100301A (ja) 2013-05-23
AU2006283904B2 (en) 2012-07-12
KR101362710B1 (ko) 2014-02-13
ATE462720T1 (de) 2010-04-15
BRPI0614968A2 (pt) 2011-10-18
CA2620125C (en) 2013-08-20
EP1922333A1 (en) 2008-05-21
CN102643337A (zh) 2012-08-22
WO2007023163A1 (en) 2007-03-01
RS51325B (sr) 2010-12-31
US7745576B2 (en) 2010-06-29
AP2008004415A0 (en) 2008-04-30
IL189135A0 (en) 2008-08-07
ZA200801426B (en) 2008-12-31
TW200734350A (en) 2007-09-16
CN101248085B (zh) 2012-05-30
US20080214450A1 (en) 2008-09-04
AR055394A1 (es) 2007-08-22
KR20080048477A (ko) 2008-06-02
DK1922333T3 (da) 2010-07-19
DE602006013330D1 (de) 2010-05-12
MX2008002485A (es) 2008-04-03
EP1922333B1 (en) 2010-03-31
NZ565926A (en) 2010-11-26
TWI386416B (zh) 2013-02-21

Similar Documents

Publication Publication Date Title
JP2005533481A5 (enExample)
HRP20251216T1 (hr) Ljudski kolagenski polipeptid tipa 17, postupak za njegovu proizvodnju i njegova primjena
JP2017141230A (ja) 美容タンパク質およびペプチドの産生のための修飾ポリヌクレオチド
RU2004118603A (ru) Противомикробные полипептиды из pstudoplectania nigrella
FI932678A7 (fi) Alfaviruksiin perustuvia DNA-ilmentämissysteemejä
RU95113418A (ru) Полипептиды, способы получения, днк, вектор, клетка, применение полипептида, фармацевтические композиции
BRPI0412799A (pt) imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura
JP2018533970A5 (enExample)
RU2007145188A (ru) Полипептиды, обладающие антимикробной активностью, и полинуклеотиды, кодирующие их
EA201170917A1 (ru) Ген, кодирующий мутантную глюкокиназу человека, кодируемый им фермент, рекомбинантные векторы и хозяева, фармацевтические композиции и их применения, способы лечения и предупреждения болезней
RU2005113692A (ru) Вакцина против hcv
MY167485A (en) Recombinant human interferon-like proteins
JP2011072294A (ja) 新規抗菌ペプチド
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
AR030430A1 (es) Procedimiento para la obtencion de quimicos finos por cultivo de organismos que presentan una via de shiquimato modificada, composicion de acido nucleinico, uso de dicho acido nucleinico para la obtencion de plantas transgenicas, organismo geneticamente modificado, procedimiento para la produccion d
CA2266421A1 (en) Genes coding for a protein having glycoside transfer activity
RU2014124139A (ru) Подобные коллагену гены шелка
JP2009507474A5 (enExample)
CN110591996A (zh) 一种高产l-赖氨酸枯草芽孢杆工程菌的构建方法及应用
CN116262781A (zh) 抗菌肽defensin衍生物及其原核表达方法与应用
RU2008111504A (ru) Полипептиды, обладающие антимикробной активностью, и полинуклеотиды, кодирующие их
CN103467569A (zh) 一种抗菌止痒消炎消肿去疤痕的短肽及其应用
RU2006119452A (ru) Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
US9365633B2 (en) Peptide preparations and peptides with antitumour activity
JP2008537675A5 (enExample)